Aptus Pharma Limited is engaged in the marketing and distribution of finished pharmaceutical formulations. Converted into a public limited company in December 2024, it operates under a contract manufacturing model without owning manufacturing facilities. The company partners with seven manufacturing units, including formal loan and license agreements with two units, while the rest function through purchase order-based arrangements. Its diverse product portfolio spans multiple therapeutic categories—such as anti-infectives, gastrointestinal, cardiovascular, anti-diabetic, neuro-psychiatric, and wellness products—offered in varied dosage forms including tablets, capsules, syrups, injections, ointments, and more.
Price Band₹65 - ₹70 |
Dates23 Sep - 25 Sep |
GMP₹0 (0.00%) |
Subscriptions- |
Issue Size₹13.02 Crs |
Price Band₹65 - ₹70 |
Listing AtBSE SME |
IPO Issue Type100% Book Built Offer |
Fresh Issue₹13.02 Cr (0.19 Cr Shares) |
Offer For Sale₹0.00 (0.00 Shares) |
Total Issue₹13.02 Cr (0.19 Cr Shares) |
Face Value₹10 per equity share |
| Investor Category | Lot | Shares | Amount | |
|---|---|---|---|---|
| Individual Investor |
Minimum
2
4,000
2,80,000
Maximum
2
4,000
2,80,000
|
|||
| Small HNI |
Minimum
3
6,000
4,20,000
Maximum
7
14,000
9,80,000
|
|||
| Big HNI |
Minimum
8
16,000
11,20,000
|
|||
The estimated Grey Market Premium of Aptus Pharma IPO is ₹0 per share (0.00%)
| Particulars | Allocation |
|---|---|
| QIB | Not more than 50% of Net Offer |
| NII | Not less than 35% of Net Offer |
| Retail | Not less than 15% of Net Offer |
| Market Maker | 94000 EQ Shares |
| KPI | Values |
|---|---|
| EBITDA | 19.31% |
| PAT | 12.62% |
| ROE | 44.50% |
| ROCE | 45.66% |
| Debt to Equity | 1.49 |
| PE Ratio | 10.99 |
| PB Ratio | 5.03 |
| Mkt Cap (in Crs.) | 48.02 |
| Name | Shareholding |
|---|---|
| Tejash Maheshchandra Hathi | 15.50% |
| Kapilbhai Hasmukhbhai Chandarana | 15.50% |
| Others | 69.00% |
| Total | 100.00% |
| Name | Designation |
|---|---|
| Tejash Maheshchandra Hathi | MD |
| Kapilbhai Chandarana | CFO |
Name: Aptus Pharma Limited
Address: Ashutosh
Buildcon, Opp. Slok - 2, Nr.
Harikrupa Logistic Park, Aslali,
Ahmedabad, Daskroi, Gujarat, India,
382427
Number: +91 76004 27827
Email: info@aptuspharma.com
Website: www.aptus-pharma.com
Find answers to common questions that come in your mind related to IPO.
Aptus Pharma IPO is a SME IPO having an issue size of Rs. ₹13.02 Crs. Aptus Pharma IPO is priced at ₹65 - ₹70 per share. The issue opens on 23 Sep 25 and closes on 25 Sep 25.
Aptus Pharma IPO opens on 23 Sep 25 and closes on 25 Sep 25.
The estimated Grey Market Premium of Aptus Pharma IPO is ₹0 per share (0.00%).
The minimum lot size of Aptus Pharma IPO is 2000 shares & the minimum application amount is Rs. 140000.
The allotment date of Aptus Pharma IPO is 26 Sep 25.
The listing date of Aptus Pharma IPO is 30 Sep 25.
Aptus Pharma IPO is subscribed -.
Aptus Pharma IPO is priced at ₹65 - ₹70 per share.
Click the allotment link on Aptus Pharma IPO page of IPO360.